Efficacy and Safety of Mirogabalin in Patients with Neuropathic Pain Due to Cervical Spondylotic Radiculopathy: Miro-Cens, A Randomized, Controlled, Interventional Study

Efficacy and Safety of Mirogabalin in Patients with Neuropathic Pain Due to Cervical Spondylotic Radiculopathy: Miro-Cens, A Randomized, Controlled, Interventional Study

Abstract Introduction There are few studies of pharmacotherapy of neuropathic pain in cervical spondylotic radiculopathy (CSR). Miro-Cens aimed to examine the efficacy and safety of mirogabalin for treating pain in patients with CSR on non-steroidal anti-inflammatory drugs (NSAIDs), compared with NS...

Full description

Saved in:
Bibliographic Details
Main Authors: Takashi Hirai, Atsushi Okawa, Hiroshi Takahashi, Kazuhito Shiosakai, Toshitaka Yoshii, On behalf of the Miro-Cens investigators
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-04-01
Series:Pain and Therapy
Subjects:
α2δ ligand
Cervical spondylotic radiculopathy
Gabapentinoid
Mirogabalin
Neuropathic pain
NSAID
Online Access:https://doi.org/10.1007/s40122-025-00722-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s40122-025-00722-w

Similar Items